TT-00420 tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TT-00420 tablet, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC. [Phase 2]